![Erik Anders Kronström](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : 78 616 $ au 31/07/2026
Erik Anders Kronström currently works at Infant Bacterial Therapeutics AB, as Chief Operating Officer from 2018.
Mr. Kronström also formerly worked at Biosergen AS, as Chief Executive Officer.
Mr. Kronström received his Masters Business Admin degree from Warwick Business School and graduate degree from Royal Institute of Technology.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/09/2025 | 11 194 ( 0,09% ) | 78 616 $ | 31/07/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| INFANT BACTERIAL THERAPEUTICS AB | Directeur des opérations | 01/01/2018 |
| Sociétés | Poste | Fin |
|---|---|---|
Biosergen AS
 Biosergen AS BiotechnologyHealth Technology Operates as a biotechnology company which develops antifungal drugs for the treatment of severe invasive fungal infections | Directeur Général | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Warwick Business School
 Warwick Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Royal Institute of Technology
 Royal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biosergen AS
Biosergen AS BiotechnologyHealth Technology Operates as a biotechnology company which develops antifungal drugs for the treatment of severe invasive fungal infections | Health Technology |
Infant Bacterial Therapeutics AB
 Infant Bacterial Therapeutics AB Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of gastroschisis | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
